ATS 2024 Final Program

Click on the session title to view the speakers

184

MONDAY • MAY 20

P693 Computational Fluid Dynamics Analysis of Small Airway Deformation in COPD P694 Placebo Controlled RCT of a Lactobacillus Probiotic and Herbal Blend in COPD Patients P695 Characterizing Chronic Obstructive Pulmonary Disease Using Alpha-1 Antitrypsin Genotype, Spirometry, and Respiratory Oscillometry P696 Asthma-COPD Overlap Patients With Elevated Blood Eosinophils: Review of Exacerbation Rates After 2 Years of Anti-IL-5 Treatment P697 Sex-specific Differences in Patients With Mild COPD and Symptomatic (ex)-smokers at Risk - Baseline Data From Capto-COPD P698 Safety Outcomes of Bronchoscopic Lung Volume Reduction in Patients With Low Diffusing Capacity P699 The Body Mass Index Adjusted Resistance and Its Role in Predicting Spirometry-defined Chronic Obstructive Pulmonary Disease P700 Audio-based Automated Cough Analysis System: A Proof of Concept Study P701 129 xe MRI With Optimized Bias Field Correction to Assess Ventilation Gradients in Individuals With Normal Lung Function P702 Follistatin and Pulmonary Function: Interlinked Factors in Weakness Among Aging Adults P703 Alpha-1-Antitrypsin Deficiency in Active-duty Military Personnel P704 Correlation of Cardiopulmonary Exercise Test With Quality of Life in Stable Chronic Obstructive Pulmonary Disease Patients Among Indonesian P705 Correlation of CAT Score With PFT Parameters (FEV1, RV/TLC, DLCO, and DLCO/VA) in COPD Patients P706 Inhaled Corticosteroids Accelerate Aging in the Airways of COPD Patients P707 Impact of Emphysema on Lung Expansion and Ventilation in COPD Patients P708 The Impact of Rate of FEV1 Decline in American and Spanish Cohorts at High Risk for Lung Cancer P709 Non-invasive Prediction of Dyspnea Severity Using Machine Learning

P710 Interim Report: IAB-1, A Multicenter, Prospective Trial of the Implantable Artificial Bronchus (IAB) in Adults Suffering From COPD/Emphysema P711 Pulmonary Effects of Electronic Cigarettes in Young Adults

BEHAVIORAL • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B80-3 OSA 2.0: LEVELING UP THE SLEEP APNEA TOOL KIT 9:15 a.m. - 4:15 p.m. San Diego Convention Center Area D (Hall A-B2, Ground Level) Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P371 High Flow Nasal Cannula for Obstructive Sleep Apnea in Parkinson’s Disease: A Pilot Study P372 Proximal Hypoglossal Nerve Stimulation Improves Self-reported Frequency and Severity of Snoring in Moderate to Severe Obstructive Sleep Apnea P373 Respiratory Features of Drug Induced Sleep Endoscopy With Propofol P374 Aroxybutynin and Atomoxetine (AD109) for the Treatment of OSA: Rationale and Design of the LUNAIRO Phase 3 Randomized, Controlled Clinical Trial P375 Impact of Body Mass Index on Cardiovascular Risk Among Patients With Obstructive Sleep Apnea: A Systematic Literature Review P376 “Neither Sleepy Nor Sleeping”: Recognizing the Existence of Novel Cinico-physiological Phenotypes of Obstructive Sleep Apnea (OSA) in Developing Country P377 Shed Some Lbs, Catch Some ZZZs: An Exploration of the Impact of Bariatric Surgery on Obstructive Sleep Apnea Severity in an Urban Community Hospital P378 The Cardiorespiratory Burden of Central and Obstructive Sleep Apnea and Risk of Respiratory Depression in Individuals on Chronic Opioids Therapy

ATS 2024 Conference Program • San Diego, CA